Introduction
Worldwide, significant bilateral hearing loss is found in between 1 and 3 of every 1 000 newborns in well-baby populations and in 2% to 4% of infants in neonate intensive care units. 1, 2, 3 Failure to detect hearing loss in a timely manner, and to intervene as possible, can lead to a disabilities in linguistic and language functioning and cognitive development and to difficulties in social functioning. Research indicates that diagnosing hearing loss in newborns within 3 months of birth and implementing appropriate treatment and interventions within 6 months of birth normalizes cognitive and language development, therefore allowing hearing-loss infants to develop at a pace similar to that of infants without hearing loss. Such studies also show that the long-term quality of life for intervened infants surpasses what would have been possible had treatment been delayed or absent.
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Research also shows more traditional detection efforts are inadequate: Only about 50% of neonates with congenital hearing loss are detected using the high-risk registry that screens for, among other items, a family history of deafness. In addition, physician examinations and parental observations only occasionally succeed in identifying congenital hearing loss in infants under the age of 1. To improve the early detection of infant hearing loss, in the past 15 years many countries and cities have instituted universal newborn hearing screening programs (UNHSPs) or have set up a series of screening measures. 1, 4, 6, 7, 8 In the United States and elsewhere, 9 UNHSPs have spread gradually, 10, 11, 12 spurred by the endorsements of a 1993 National Institutes of Health Consensus Development
Conference and, in 1994, by the American Academy of Pediatrics (AAP). The AAP's findings set a goal of universal detection of hearing loss in infants before 3 months of age coupled with appropriate intervention no later than 6 months of age. Both groups advocated hearing loss screening for all newborns before hospital discharge. 1, 4, 13, 14 In 2003, an analysis of UNHSPs in the United States showed 58% employed a two-stage process-initial inpatient screening in birth hospital followed by outpatient screening before 3 months of age-and achieved a first-stage screening rate of 70% among eligible newborns. After a second-stage screening, 56% of infants were referred for diagnosis by 3 months of age and 53% of the infants diagnosed with hearing loss received an appropriate intervention by 6 months of age. 18, 19, 20, 21 According to an epidemiological survey undertaken in Shanghai, between 600 and 700 of the 78 762 infants born in 1999 had some congenital defect. Furthermore, the rate of disability for children under 7 years of age was 0·968% with 16% of that group suffering from hearing loss. 22 In 2000 Shanghai's government initiated a strategy for developing effective monitoring and intervention techniques that might limit or prevent disabilities in newborns. The strategy concentrates on three areas of public health importance:
genetic testing and counseling before pregnancy, prenatal screening for congenital disabilities (such as Down's syndrome), and newborn screening for hearing loss. To address the strategy's hearing loss screening concentration, we developed a public health universal hearing loss screening procedure that was systematically designed to ensure cross-program consistency in all key aspects: instrumentation, diagnosis and screening procedures, interventions, administration and organization, personnel training, and quality control of methods and outcomes. Overall, we sought to ensure our program would meet the needs of Shanghai's population and meet-or exceed-world standards.
Methods

Network infrastructure
All 105 of Shanghai's delivery hospitals, both obstetrics and gynecology hospitals and obstetrics and gynecology departments in general hospitals, participated in the study. Milford, NJ, USA). This instrument was selected after an analysis of its technical performance and cost, a review that used reports on its ease of use and clinical performance from experts in hearing screening systems. We adopted the World Health
Organization's criteria for hearing screening (Table 1) . Regular training sessions were arranged for the hospital personnel who would be conducting the screenings; participants were granted work permits upon passing a proficiency examination.
Nominal fees of 20RMB (2·50 US$) for one ear and 40RMB (5·00 US$) for both ears were set. Standardized processes were established for information collection and quality control.
Pilot studies
We carried out a one-year pilot study (September 2000 to August 2001) to determine participation rates for screenings on an outpatient basis alone (day 42), and for inpatient screenings conducted on either the first, second, or third day following birth.
In addition, we conducted an internal comparison of the inpatient results, including images of the outer surfaces of the infants' tympanums and results from tests using high frequency acoustic impedance technology, to determine the status of eardrum effusion in neonates assessed on each of the three days. A total of 5 000 infants were screened in the pilot study: 2 000 during outpatient checkups at birth hospitals on day 42 and 1 000 on each of the first, second, and third days following birth prior to hospital discharge. Interventions included the use of audiphones within 6 months of diagnosis for infants with slight to moderate hearing loss as well as for some with severe hearing loss.
Interventions for infants with severe and extremely severe hearing loss consisted of the surgical implantation of artificial cochlear devices within 1 year of birth. Implantations were performed at two hospitals; all infants who needed implants received them. In addition, all intervened infants received aural and language training at one of the three rehabilitation centers participating in the study.
Sociological measures
In 2003 at 6 of the participating hospitals, 400 parents, either the father or the mother, of infants receiving positive results in the first-stage screening were randomly selected for face-to-face interviews. Interview questions were designed to assess parental satisfaction with the screening process. In addition, 110 of the 400 parents responded to questions that would help assess the level of anxiety or stress they felt upon learning their infants had initially screened positive for hearing loss.
Results
A comparison of data from the pilot study indicated first-stage inpatient screenings would be most effective, that is, less likely to result in false positive reports, if conducted on the 3 rd day following birth. Imaging of the outer surface of the tympanum and acoustic checks using high frequency impedance detection technology showed tympanic effusion rates decreased dramatically in the three-day period following birth.
According to our data, an effusion rate of up to 70% was found in the 1 000 infants screened on the first day post birth. This rate dropped to 30% in infants screened the second day and approached zero in the 1 000 infants screened on the third day post birth. Since the presence of amniotic fluid interfered with acoustic transmissions, we determined that TEOAE screenings would yield the fewest false positive results if conducted on the third day following birth.
Our preliminary assessment also supported a two-stage screening process begun on the third day following birth and repeated if needed on day 42. We found that initial inpatient screening achieved high participation, but also produced a high number of false positives. Families receiving a positive diagnosis were motivated to attend the second screening: The majority of Chinese families have one child, so learning that the child may be hearing impaired caused parents great anxiety. The second screening, with its promise of further defining, perhaps even nullifying, the initial diagnosis, spurred compliance. In addition, by ensuring diagnosis by 3 months of age and intervention by 6 months, families were encouraged to pursue the timely potential benefits of participation in the program.
By lessening the number of false positives, the two-stage screening also greatly reduced the number of infants referred for diagnosis. If the 13·14% of infants who screened positive in the initial stage had all been referred for diagnosis, we estimate we would have needed 12 diagnosis centers to handle the referral load. With the two-stage testing, referrals totaled fewer than 2 000 per year, a number that could be handled by three centers efficiently and well.
During the study period, 616 780 infants were born in delivery hospitals in Shanghai.
Of that group of eligible infants, 90·86% (560 412 were reported in 14·75% (6 601) of the infants. Overall, the two-stage screening process achieved a 72·98% screening rate among eligible infants ( Figure 3 , Table 4 ). To help understand the success of our high rate of participation in both stages of screening, it is useful to know that annually 51% of the 100 000 infants born in
Shanghai are children of parents who have moved to the city to take temporary work.
These parents usually return to their home province after childbirth. If they then return to Shanghai after recuperating from delivery, their newborns are generally left with the grandparents in the home province. Ninety percent of the infants born to these temporary workers, known as the "floating population," are not taken to their birth hospital for a return visit on day 42.
Among Shanghai residents, failure to return for a second screening on day 42 (15% of the remaining 49% of infants and families who did not follow-up), was attributed to economic concern, a lack of faith in the process, afraid of getting in trouble because of a negative diagnosis, and the like.
Of the infants referred to diagnostic centers, 1·46 per 1 000 of those from the first-stage screening (a total of 818) received a diagnosis of permanent deafness within 3 months of birth. The majority of diagnoses showed slight to moderate hearing loss in referred infants (33·98%, or 278 infants, and 55·37%, or 453 infants, respectively) with only a 3·42% (28 infants) found to have extremely severe hearing loss. Bilateral deafness was diagnosed in 82·40% of the referred newborns (674) and single-ear deafness in 17·60%
(144) of the infants (Table 1) .
Among the permanently deaf infants receiving interventions, 86·31% (706) had effective interventions within 6 months. (Table 4) Interviews with 400 randomly selected parents revealed 90% were satisfied with the screening process and their knowledge of it (Table 2) . At the same time, the cohort of 110 parents interviewed for their level of anxiety indicated they had suffered a high degree of mental stress upon learning their child had tested positive for hearing loss (Table 3 ).
Discussion
Our study showed a government-sponsored public health universal newborn hearing screening program can be effectively coordinated and carried out in a large, complex city such as Shanghai. To our knowledge, our effort has developed the first successful model of a public health UNHSP.
The integrated design of our study included an initial inpatient screening, a second screening on an outpatient basis, and coordinated diagnosis and intervention services (including free audiphones, surgical implantation of cochlear devices, and aural and language training). It resulted in high rates of participation for both the initial and the second screenings; reduced false positive rates at second screenings; widespread access to participating centers, and prompt and effective interventions that placed no economic burden on the parents of the infants.
In addition, we believe our study shows that implementing a well-organized program that adheres to uniform screening, training, and intervention standards can achieve high compliance rates and high rates of satisfaction from families involved in the The study's outcomes are not without shortfalls and limitations, however. Why did 9% of eligible infants fail to take part in the inpatient screening? Although we had a high rate of participation in the 3 rd day screening, we had no mechanism in place to Economic concern for treatment 6.60 8 
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